Dipeptidyl Peptidase-4 Stabilizes Integrin α4β1 Complex to Promote Thyroid Cancer Cell Metastasis by Activating Transforming Growth Factor-Beta Signaling Pathway

• Published in: Thyroid (New York, N.Y.) Vol. 32; no. 11; p. 1411
• Main Authors: He, Qingyuan, Cao, Hongxin, Zhao, Yuelei, Chen, Pu, Wang, Na, Li, Wenyuan, Cui, Rongrong, Hou, Peng, Zhang, Xiaozhi, Ji, Meiju
• Format: Journal Article
• Language: English
• Published: United States 01.11.2022
• Subjects: Animals; Cell Line, Tumor; Cell Movement; Dipeptidyl Peptidase 4 - genetics; Dipeptidyl Peptidase 4 - metabolism; Dipeptidyl Peptidase 4 - pharmacology; Dipeptidyl-Peptidase IV Inhibitors - pharmacology; Epithelial-Mesenchymal Transition; Integrin alpha4beta1; Mice; Proto-Oncogene Proteins c-akt - metabolism; Signal Transduction; Sitagliptin Phosphate - pharmacology; Thyroid Neoplasms - genetics; Thyroid Neoplasms - metabolism; Transforming Growth Factor beta1 - metabolism; Transforming Growth Factor beta1 - pharmacology; Transforming Growth Factors - pharmacology; DPP4; integrins; thyroid cancer; tumor metastasis; TGF-β signaling
• DOI: 10.1089/thy.2022.0317

Metastatic disease is a major cause of thyroid cancer-related death. However, the mechanisms responsible for thyroid cancer metastasis are unclear. Dipeptidyl peptidase-4 (DPP4) is a multifunctional cell surface glycoprotein that has been reported to be a negative prognostic factor in thyroid cancer. We explored the molecular mechanism of the role of DPP4 in thyroid cancer cell metastasis. The effects of DPP4 on thyroid cancer cell migration/invasion were assessed by transwell assays. A lung metastatic mouse model was also established to determine the effect of DPP4 on tumor metastasis . DPP4 inhibitor sitagliptin was used to test its effect on thyroid cancer cell metastasis. The mechanism of which DPP4 promotes thyroid cancer cell metastasis was explored by a series of molecular and biochemical experiments. We observed that DPP4 was significantly upregulated in papillary thyroid cancers compared with control subjects, and its expression was positively associated with lymph node metastasis and mutation. Functional studies showed that DPP4 knockdown significantly inhibited metastatic potential of thyroid cancer cells, and . However, DPP4 inhibitor sitagliptin did not affect the metastatic ability of thyroid cancer cells, indicating that the promoting effect of DPP4 on tumor metastasis was independent of its enzymatic activity. Mechanistically, DPP4 interacted with the α4 and β1 integrin subunits, and stabilized the formation of integrin α4β1 complex. DPP4-mediated integrin signal activation promoted the nuclear localization of c-Jun through the FAK/AKT pathway, thereby inducing the transcription of transforming growth factor-beta 1 ( coding for protein TGF-β1). TGF-β1 then facilitated tumor metastasis by inducing the epithelial-mesenchymal transition. DPP4 promotes thyroid cancer cell metastasis through the integrins/FAK/AKT/c-Jun/TGF-β1 signaling axis. These findings may have implications for an alternative therapeutic strategy for thyroid cancer.